Newsroom
September 14, 2020
Dr. Carlayne Jackson, professor of neurology and otolaryngology, co-authored a new study that includes the results of a small clinical trial for an oral drug that slowed ALS patients’ rate of functional decline. Read and watch the story.
September 11, 2020
A neuro-intensive care physician at UT Health San Antonio has invented a science-based way to stop hiccups. The device is called HiccAway.
September 10, 2020
If the finding is repeated in larger trials, the drug could give families more time with their loved ones who have ALS.
September 8, 2020
Although it’s not a cure for ALS, an oral drug slowed patients’ rate of functional decline in a clinical trial that included five patients at UT Health San Antonio. If the finding is repeated in larger trials, the drug could give families more time with their loved ones who have ALS. The New England Journal […]
August 25, 2020
In the war on cancer and other diseases including COVID-19, old drugs approved for other conditions are being studied for new purposes. It’s a strategy that will now be tested in Alzheimer’s disease with a drug called rapamycin. A $2 million grant will enable a clinical trial in which 40 individuals with mild cognitive impairment […]
August 20, 2020
The Cancer Prevention and Research Institute of Texas awarded more than $10.3 million to the Mays Cancer Center.
